Prognostic factors in breast cancer patients following neoadjuvant chemotherapy

被引：0
|
作者：
Kim, JR [1 ]
Chang, ES [1 ]
机构：
[1] Chungnam Natl Univ, Dept Surg, Taejon 305764, South Korea
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2005年 / 59卷
关键词：
breast cancer; neoadjuvant chemotherapy; axillary lymph node;
D O I：
10.1016/S0753-3322(05)80093-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S395 / S396
页数：2
相关论文
共 50 条
  • [21] Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
    Kawajiri, Hidemi
    Takashima, Tsutomu
    Aomatsu, Naoki
    Kashiwagi, Shinichiro
    Noda, Satoru
    Onoda, Naoyoshi
    Ishikawa, Tetsurou
    Hirakawa, Kosei
    ONCOLOGY LETTERS, 2014, 7 (03) : 663 - 668
  • [22] Factors predicting a pathological complete response following neoadjuvant chemotherapy for breast cancer
    Choi, H.
    Van Belle, V.
    Wildiers, H.
    Paridaens, R.
    Amant, F.
    Van Limbergen, E.
    Moerman, P.
    Smeets, A.
    Vergote, I.
    Neven, P.
    EJC SUPPLEMENTS, 2010, 8 (03): : 66 - 67
  • [23] Factors predicting disease free survival following neoadjuvant chemotherapy for breast cancer
    Van Belle, V.
    Cho, H.
    Wildiers, H.
    Van Huffel, S.
    Paridaens, R.
    Weltens, C.
    Berteloot, P.
    Janssen, H.
    Christiaens, M. R.
    Neven, P.
    EJC SUPPLEMENTS, 2010, 8 (03): : 101 - 101
  • [24] Neoadjuvant chemotherapy in patients with breast cancer
    Jakesz, R
    Taucher, S
    Gnant, M
    Gebhard, B
    Kandioler, D
    Rudas, M
    Djavanmard, M
    Steger, G
    ZENTRALBLATT FUR CHIRURGIE, 1998, 123 : 147 - 150
  • [25] Prognostic value of hormone receptor status conversion following neoadjuvant chemotherapy in a series of operable breast cancer patients
    Tan, Qi-Xing
    Qin, Qing-Hong
    Yang, Wei-Ping
    Lian, Bin
    Wei, Chang-Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (07): : 4086 - 4094
  • [26] Risk factors of breast cancer recurrence in pathologic complete response achieved patients following neoadjuvant chemotherapy
    Choi, J. Y.
    Woen, D.
    Jang, S. Y.
    Lee, H.
    Shin, D. S.
    Kwak, Y.
    Chae, B. -J.
    Yu, J.
    Kim, S. W.
    Lee, J. E.
    Nam, S. J.
    Ryu, J. M.
    BREAST, 2023, 68 : S72 - S72
  • [27] Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
    Maria D Cao
    Guro F Giskeødegård
    Tone F Bathen
    Beathe Sitter
    Anna Bofin
    Per E Lønning
    Steinar Lundgren
    Ingrid S Gribbestad
    BMC Cancer, 12
  • [28] Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
    Li, Xinyan
    Wang, Mozhi
    Wang, Mengshen
    Yu, Xueting
    Guo, Jingyi
    Sun, Tie
    Yao, Litong
    Zhang, Qiang
    Xu, Yingying
    JOURNAL OF BREAST CANCER, 2019, 22 (04) : 497 - 521
  • [29] Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Ozdemir, Ozlem
    Zengel, Baha
    Cavdar, Demet Kocatepe
    Yilmaz, Cengiz
    Durusoy, Raika
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (02) : 167 - 171
  • [30] Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
    Cao, Maria D.
    Giskeodegard, Guro F.
    Bathen, Tone F.
    Sitter, Beathe
    Bofin, Anna
    Lonning, Per E.
    Lundgren, Steinar
    Gribbestad, Ingrid S.
    BMC CANCER, 2012, 12
12345